109 results
Page 2 of 6
8-K
EX-99.2
jciyk4730bm kblgeho
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
1r8mru
4 May 23
Results of Operations and Financial Condition
4:02pm
8-K
EX-99.1
pidsmb0k1 llkz
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
EX-99.2
88t6n2g9i l3
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
EX-99.1
n16p7
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
EX-99.1
qt7uj ufmyczkmk5
9 Nov 22
Results of Operations and Financial Condition
7:30am
8-K
EX-99.1
8iy080c3w
24 Oct 22
Regulation FD Disclosure
8:46am
8-K
EX-1.1
90dy5uz
10 Aug 22
Other Events
12:00am
8-K
EX-99.1
t5kee5u9wrbtrz17csnr
4 Aug 22
Results of Operations and Financial Condition
4:03pm
8-K
EX-99.1
9ga28 0hdz8oe0y84e
6 Jun 22
Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors
8:32am
8-K
EX-99.1
x4hchv6bovwqi69p4h
5 May 22
Results of Operations and Financial Condition
8:05am
8-K
EX-99.1
6s0odryn6tjho
9 Mar 22
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
2bd q487h
11 Jan 22
Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones
9:00am